The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease Diagnosis: The Italian Selfie-Reference-Cited by-同舟云学术

The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease Diagnosis: The Italian Selfie

Published:2016-12-20 Issue:4 Volume:55 Page:1659-1666
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Sancesario Giulia M.¹,Toniolo Sofia²,Chiasserini Davide³,Di Santo Simona G.¹²,Zegeer Josh⁴,Bernardi Gaetano⁵,Musicco Massimo⁶,Caltagirone Carlo¹²,Parnetti Lucilla³,Bernardini Sergio⁴, ,

Affiliation:

1. Department of Clinical and Behavioural Neurology, Santa Lucia Foundation, Rome, Italy

2. Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy

3. Department of Medicine, Center for Memory Disturbances, University of Perugia, Italy

4. Department of Experimental Medicine and Surgery, Tor Vergata University of Rome, Rome, Italy

5. C. Besta Neurologic Foundation, Milan, Italy

6. Epidemiology and Biostatistics Unit, Institute of Biomedical Technologies, National Research Council, Milan, Italy

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference31 articles.

1. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease;Blennow;Alzheimers Dement,2015

2. CSF markers for incipient Alzheimer’s disease;Blennow;Lancet Neurol,2003

3. Cerebrospinal fluid tau and beta-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?;Clark;Arch Neurol,2003

4. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment;de Leon;Neurobiol Aging,2006

5. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults;Fagan;Arch Neurol,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease;Biomedicines;2022-10-21

2. Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer’s Disease Framework;Journal of Alzheimer's Disease;2022-04-05

3. Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters;Frontiers in Neurology;2022-02-25

4. Using the ATN system as a guide for the neuropsychological assessment of Alzheimer’s disease;Journal of Clinical and Experimental Neuropsychology;2021-10-21

5. Artificial Intelligence for Alzheimer’s Disease: Promise or Challenge?;Diagnostics;2021-08-14